SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-534596
Filing Date
2016-04-08
Accepted
2016-04-08 07:00:32
Documents
8
Period of Report
2016-05-19
Effectiveness Date
2016-04-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A d123896ddef14a.htm DEF 14A 322215
2 GRAPHIC g123896g11y77.jpg GRAPHIC 26592
3 GRAPHIC g123896g21j11.jpg GRAPHIC 24658
4 GRAPHIC g123896g29z90.jpg GRAPHIC 25448
5 GRAPHIC g123896g34w95.jpg GRAPHIC 27454
6 GRAPHIC g123896g56z83.jpg GRAPHIC 16586
7 GRAPHIC g123896g57f70.jpg GRAPHIC 22487
8 GRAPHIC g123896g70z84.jpg GRAPHIC 43712
  Complete submission text file 0001193125-16-534596.txt   581447
Mailing Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139 617-401-0011
Dimension Therapeutics, Inc. (Filer) CIK: 0001592288 (see all company filings)

IRS No.: 463942159 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37601 | Film No.: 161561297
SIC: 2836 Biological Products, (No Diagnostic Substances)